Dr Swetha Sridharan
FRANZCR, MBBS, Radiation Oncologist
For patients/carers
For doctors
FRANZCR, MBBS, Radiation Oncologist
Biography
Clinical interests include cancers of the lower gastrointestinal tract, urogenital system, gynaecological cancers, and liver and kidney cancers.
Dr Swetha Sridharan is a Radiation Oncologist based in Gateshead, NSW, with expertise in the management of genitourinary, gastrointestinal and gynaecological cancers. She is committed to delivering compassionate, evidence-based care and works collaboratively within multidisciplinary teams to develop personalised treatment plans, incorporating advanced radiotherapy techniques.
Recognised for her patient-centred approach and clear, empathetic communication, Dr Sridharan supports patients and their families throughout their cancer journey, while maintaining a strong focus on clinical excellence and ongoing professional development.
More information
- Royal Australian and New Zealand College of Radiologists (RANZCR)
- Trans Tasman Radiation Oncology Group (TROG)
- GOROC
- Shore, N. D., de Almeida Luz, M., De Giorgi, U., Gleave, M., Gotto, G. T., Pieczonka, C. M., Haas, G. P., Kim, C.-S., Ramirez-Backhaus, M., Rannikko, A., Kalac, M., Sridharan, S., Rosales, M., Tang, Y., Tutrone, R. F. Jr, Venugopal, B., Villers, A., Woo, H. H., Wang, F., & Freedland, S. J. (2025). Improved survival with enzalutamide in biochemically recurrent prostate cancer. The New England Journal of Medicine. Advance online publication. https://doi.org/10.1056/NEJMoa2510310
- Freedland, S. J., de Almeida Luz, M., De Giorgi, U., Gleave, M., Gotto, G. T., Pieczonka, C. M., Haas, G. P., Kim, C.-S., Ramirez-Backhaus, M., Rannikko, A., Kalac, M., Sridharan, S., Rosales, M., Tang, Y., Tutrone, R. F., Venugopal, B., Villers, A., Woo, H. H., Wang, F., … Shore, N. D. (2023). Improved outcomes with enzalutamide in biochemically recurrent prostate cancer. The New England Journal of Medicine, 389(16), 1453–1465. https://doi.org/10.1056/NEJMoa2303974
- Siva, S., Chesson, B., Bressel, M., Pryor, D., Higgs, B., Reynolds, H. M., Hardcastle, N., Montgomery, R., Vanneste, B., Khoo, V., Ruben, J., Lau, E., Hofman, M. S., Lourenço, R. D. A., Sridharan, S., Brook, N. R., Martin, J., Lawrentschuk, N., Kron, T., & Foroudi, F. (2018). TROG 15.03 phase II clinical trial of focal ablative stereotactic radiosurgery for cancers of the kidney: FASTRACK II. BMC Cancer, 18(1), Article 1030. https://doi.org/10.1186/s12885-018-4916-2